ADHD in women is systematically under-diagnosed, under-treated, and under-researched. The consequences — for mental health, relationships, and quality of life — are significant. Here is what clinicians and patients need to know.
A Different Presentation
ADHD in women is not the same as ADHD in men — or rather, it does not always look the same. The hyperactive, disruptive presentation that has historically defined the clinical picture of ADHD is more common in boys and men. Women and girls are more likely to present with inattentive-type ADHD: difficulty sustaining attention, mental restlessness, disorganisation, emotional dysregulation, and a pervasive sense of underachievement that is often attributed to anxiety, depression, or simply "not trying hard enough."
The result is a diagnostic gap that has been well-documented but insufficiently addressed. Girls with ADHD are diagnosed, on average, several years later than boys. Women with ADHD frequently receive multiple other diagnoses — anxiety, depression, borderline personality disorder — before anyone considers ADHD. And many women reach adulthood, or even middle age, without ever receiving an accurate diagnosis.
The Masking Problem
A key factor in the under-diagnosis of ADHD in women is masking — the learned behaviour of concealing or compensating for ADHD symptoms in order to meet social expectations. Girls are socialised from an early age to be organised, attentive, and compliant. Those with ADHD learn to work harder to meet these expectations, developing coping strategies that hide their difficulties from teachers, parents, and eventually clinicians.
Masking is exhausting. The cognitive and emotional effort required to maintain it — to appear "normal" while managing a brain that works differently — takes a significant toll. Many women with undiagnosed ADHD describe a chronic sense of fatigue, inadequacy, and anxiety that they cannot explain. The relief that comes with a late diagnosis is often profound: finally, an explanation that makes sense of a lifetime of struggle.
Hormonal Interactions
ADHD symptoms in women are significantly affected by hormonal fluctuations across the lifespan. Oestrogen has a modulatory effect on dopamine — the neurotransmitter most closely associated with ADHD — which means that symptoms often worsen at times of hormonal change: the premenstrual phase, the perimenopause, and the postpartum period.
Many women report that their ADHD symptoms become significantly more severe in their 40s and 50s, as oestrogen levels decline during perimenopause. This is a period when ADHD is often first diagnosed — or when a previously managed condition becomes unmanageable. Clinicians working with perimenopausal women presenting with cognitive difficulties, mood instability, and executive function problems should have ADHD on their differential diagnosis.
Assessment and Treatment at Cardinal Clinic
At Cardinal Clinic, our ADHD assessment process is comprehensive, taking into account the full clinical picture including developmental history, current symptom profile, co-occurring conditions, and the specific ways in which ADHD presents in women. Our treatment approach is multimodal, combining medication management where appropriate with psychological support, coaching, and practical skills development.
We are particularly experienced in working with women who have received a late diagnosis — navigating the complex emotional process of understanding a lifetime of experiences through a new lens, and building the skills and strategies needed to thrive.